Multi‐cohort analysis identifies somatic NTRK mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanoma

• Junya Yan,
• Long Deng,
• Jiayi Yu,
• Xiaowen Wu,
• Shaoyu Wang,
• Shundong Cang

Affiliations

Junya Yan

Department of OncologyHenan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's HospitalZhengzhou China

Long Deng

Western Medical Branch of the Chinese PLA General Hospital Beijing China

Jiayi Yu

Department of Radiation Oncology Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) Peking University Cancer Hospital & Institute Beijing China

Xiaowen Wu

Department of Renal Cancer and Melanoma Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) Peking University Cancer Hospital & Institute Beijing China

Shaoyu Wang

Henan Key Laboratory of Imaging and Intelligent Processing PLA Strategic Support Force Information Engineering University Zhengzhou China

Shundong Cang

Department of OncologyHenan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's HospitalZhengzhou China